A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 4, 2013, Pages 703-708

  Pu, Juan ^a   Qin, Shan Shan ^b   Ding, Jin Xia ^b   Zhang, Yan ^b   Zhu, Wei Guo ^b   Yu, Chang Hua ^b   Li, Tao ^b   Tao, Guang Zhou ^b   Ji, Fu Zhi ^b   Zhou, Xi Lei ^b   Han, Ji Hua ^b   Ji, Ya Lin ^b   Sun, Jun Xia ^b  

^a Department of Radiation Oncology   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Early stage cervical cancer; High risk factor; Post surgery; Radiotherapy

Indexed keywords

CISPLATIN; DEXAMETHASONE; DOCETAXEL;

ADULT; AGED; ARTICLE; BLADDER DISEASE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; EARLY CANCER; ENTEROPATHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LYMPH VESSEL METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; SKIN TOXICITY; TUMOR VOLUME; URETER DISEASE; URINARY TRACT DISEASE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE; TAXOIDS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84876416488     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1373-9     Document Type: Article

References (23)

1. Delgado G, Bundy B, Fowler WC et al (1989) A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecological Oncology Group study. Gynecol Oncol 35(3):314-320
2. Green JA, Kirwan JM, Tierney JF et al (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358(9284):781-786
3. Keys HM, Bundy BN, Stehman FB et al (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340(15):1154-1161
4. Lahousen M, Haas J, Pickel H et al (1999) Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, prospective, multicenter trial. Gynecol Oncol 73(2):196-201
5. Lai CH, Hong JH, Hsueh S et al (1999) Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer 85(7):1537-1546
6. Landoni F, Maneo A, Lolombo A et al (1997) Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350(9077):535-540
7. Marchiola P, Buenerd A, Benchaib M et al (2005) Clinical significance of lymphovascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 97(3):727-732
8. McGuire WP, Blessing JA, Moore DH et al (1996) Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group study. J Clin Oncol 14(3):792-795
9. Moore DH, Blessing JA, McQuellon RP et al (2004) Phase III study of cisplatin with or without paclitaxel in stage IV, recurrent or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 22:3113-3119
10. Morris M, Eifel PJ, Lu J et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340(15):1137-1143
11. Papadimitriou CA, Sarris K, Moulopoulos LA et al (1999) Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 17(3):761-766
12. Peters WA III, Liu PY, Barrett RJ II et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18(18):1606-1613
13. Rose PG, Bundy BN, Watkins EB et al (1999a) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340(15):1144-1153
14. Rose PG, Blessing JA, Gershenson DM et al (1999b) Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 17(9):2676-2680
15. Rotman M, Sedlis A, Piedmonte MR et al (2006) A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65(1):169-176
16. Samlal RA, van der Velden J (1999) Early cervical carcinoma: how to manage high-risk patients after radical hysterectomy. Eur J Obstet Gynecol Reprod Biol 85(2):137-139
17. Schorge JO, Molpus KL, Koelliker D et al (1997) Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol 66(1):31-35
18. Sedlis A, Bundy BN, Rotman MZ et al (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 73(2):177-183
19. Sit AS, Kelley JL, Gallion HH et al (2004) Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix. Cancer Invest 22(15):368-373
20. Thigpen T, Shingleton H, Homesley H et al (1981) Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 48(4):899-903
21. Thigpen JT, Blessing JA, DiSaia PJ et al (1989) A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study. Gynecol Oncol 32(2):198-202
22. Tishler RB, Schiff PB, Geard CR et al (1992) Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys 22(3):613-617
23. Whitney CW, Sause W, Bundy BN et al (1999) Randomized comparison of fluorouracil plus cisplatin vs. hydroxyurea as an adjunct to radiation therapy in stage IIB-IIIA carcinoma aortic lymph nodes: a Gynecologic Oncology Group and South-west Oncology Group Study. J Clin Oncol 17(5):1339-1348